EJP PHARMACEUTICAL ApS: Financial statements 2013
CVR: 87923614
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -394,863 and a net result of DKK 1,207,989 compared with DKK 2,559,450 the year before. Equity in the 2013 report amounted to DKK 8,452,867. The solvency ratio was 99.1%.
- Gross Profit
- DKK -394,863
- Profit/Loss
- DKK 1,207,989
- Equity
- DKK 8,452,867
- Total Assets
- DKK 8,529,827
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -395 t. | 1.2 mio. | 8.5 mio. | - |
| 2012 | - | -648 t. | 2.6 mio. | 27.2 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
EJP PHARMACEUTICAL ApS has published its annual report for 2012. Gross profit came to DKK -647,692, and the net result was DKK 2,559,450.
As of January 17, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of EJP PHARMACEUTICAL ApS.
As of January 17, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of EJP PHARMACEUTICAL ApS.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity in the 2025 report amounted to DKK 814,282.